Share this story:

Medxtractor Corp. ("MXT") enters a Market Making Services Agreement (the "Agreement") with Venture Liquidity Providers Inc. ("VLP") and initiates a visibility program with CFN Enterprises Inc. ("CFN")





Calgary, Alberta - TheNewswire May 12, 2020.

MXT reports that it has retained VLP to provide market-making services and will trade the securities of MXT on the CSE, on a best efforts-based basis, for the purposes of maintaining an orderly market and improving the liquidity in MXT's shares. Beyond a monthly trading report, there are no specific performance requirements. In consideration of the services provided by VLP, MXT will pay VLP a monthly cash fee of $5,000.00 for an initial term of three months with an automatic renewal for one-month periods after the initial term. After four months from the date of signing, the Agreement may be cancelled by either party without notice. Medxtractor and VLP are unrelated and unaffiliated entities and VLP will not receive shares or options as compensation. The capital used for market making will be provided by VLP.

MXT has also entered a three month contract with CFN to provide market visibility services at a rate of US$9000 per month. CFN is the operator of the PsyIndex, an index of psychedelic-related companies that ranks top 5 on Google for psychedelics/mushroom company investment searches. MXT is now listed on the PsyIndex that can be seen at www.psyindex.com/companies.

 

ABOUT MEDXTRACTOR CORP:

 

The Corporation is a Calgary-based company that generates technologically-based solutions. With installations all over the world, its patented craft-scale bio-extractors are used to extract compounds from a variety of botanical materials. The SHAMAN division is focusing on applying machine learning to predict potential benefits associated with the use of psychedelic drugs within the mental health misdiagnosis problem and the mHealth division is developing a consumer mHealth applications.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

MEDXTRACTOR CORP.

James M. Durward, President and CEO

Telephone: (403) 689-3901

Email:   jimd@medxtractor.com

Website: www.medxtractor.com

 

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States.  The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

 

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

 

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.